# FDA Inspection 1304602 - Therapak Corporation - February 12, 2026

Source: https://www.keypedia.com/records/fda_inspections/therapak-corporation/3552cdb8-8d0f-4317-82d6-d64cb29b703a
Source feed: FDA_Inspections

> FDA Inspection 1304602 for Therapak Corporation on February 12, 2026. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1304602
- Company Name: Therapak Corporation
- Inspection Date: 2026-02-12
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Product Evaluation: Medical Devices
- Product Type: Medical Devices & Rad Health
- Office Name: Los Angeles District Office

## Related Documents

- [FDA Inspection 1304602 - 2026-02-12](https://www.keypedia.com/records/fda_inspections/therapak-corporation/255d28c9-1faa-403e-8905-c09a397f9f25)
- [FDA Inspection 1119689 - 2020-02-05](https://www.keypedia.com/records/fda_inspections/therapak-corporation/008a8660-d1e7-4609-b660-e33249f2b1c5)
- [FDA Inspection 1119689 - 2020-02-05](https://www.keypedia.com/records/fda_inspections/therapak-corporation/15cb7caa-ee5c-4915-812d-03bf259b9882)
- [FDA Inspection 925747 - 2015-04-24](https://www.keypedia.com/records/fda_inspections/therapak-corporation/96c195cf-89b6-4b3a-a4ae-d93374ab1f38)
- [FDA Inspection 925747 - 2015-04-24](https://www.keypedia.com/records/fda_inspections/therapak-corporation/128a64d6-7bbd-47f1-b470-7013a1d94ad9)

Company: https://www.keypedia.com/companies/therapak-corporation/1a9ffab2-008a-4396-9e24-94bdc8fa916e

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b